A phase 2 study of LC 002 (DermaVir patch) in patients co-infected with HIV-1 and hepatitis C infections.
Phase of Trial: Phase II
Latest Information Update: 22 May 2012
At a glance
- Drugs LC 002 (Primary)
- Indications Hepatitis C; HIV-1 infections
- Focus Adverse reactions; Pharmacodynamics
- 22 May 2012 New trial record